Martin Capital Partners LLC Acquires 14,042 Shares of Procter & Gamble Company (The) $PG

Martin Capital Partners LLC grew its holdings in Procter & Gamble Company (The) (NYSE:PGFree Report) by 38.4% during the 2nd quarter, Holdings Channel reports. The fund owned 50,645 shares of the company’s stock after buying an additional 14,042 shares during the period. Procter & Gamble comprises 2.7% of Martin Capital Partners LLC’s portfolio, making the stock its 13th biggest holding. Martin Capital Partners LLC’s holdings in Procter & Gamble were worth $7,427,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of PG. E Fund Management Hong Kong Co. Ltd. raised its holdings in Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Litman Gregory Wealth Management LLC purchased a new stake in Procter & Gamble in the fourth quarter worth about $26,000. Park Square Financial Group LLC raised its stake in shares of Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after buying an additional 71 shares during the period. Evolution Wealth Management Inc. lifted its position in shares of Procter & Gamble by 1,315.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after buying an additional 171 shares in the last quarter. Finally, Basso Capital Management L.P. bought a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $28,000. Institutional investors own 65.77% of the company’s stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Strategic acquisition strengthens growth prospects. Thorne will complement P&G’s existing health brands, including Metamucil, Align Probiotic and New Chapter, while adding exposure to the premium wellness market. The deal is expected to close later this year. L Catterton Announces Sale of Thorne to The Procter & Gamble Company for $3.8 Billion
  • Positive Sentiment: Management is emphasizing healthcare growth. CEO Shailesh Jejurikar said the Thorne purchase is intended to grow P&G’s health business, and reports characterized the asset as a strong strategic fit. Investors may view the move as a way to diversify beyond slower-growing household and personal-care categories. Procter & Gamble will acquire supplements brand Thorne
  • Positive Sentiment: Input-cost pressure may be easing. Coverage points to cooling commodity and other input pressures, which could provide some relief to margins if the trend continues. Why Is Procter & Gamble in Focus as Input Pressures Cool?

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Raymond James Financial reduced their target price on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a report on Tuesday, April 14th. Piper Sandler upped their price target on shares of Procter & Gamble from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Friday, April 24th. The Goldman Sachs Group reduced their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a research note on Wednesday, April 8th. UBS Group raised their price objective on shares of Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Finally, Barclays upped their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $161.52.

View Our Latest Report on PG

Procter & Gamble Trading Up 2.1%

Procter & Gamble stock opened at $147.99 on Wednesday. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The firm’s 50 day moving average price is $147.81 and its 200-day moving average price is $148.97. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.68 and a quick ratio of 0.47. The stock has a market cap of $344.61 billion, a P/E ratio of 22.36, a PEG ratio of 4.45 and a beta of 0.39.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The firm had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.25%. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.

About Procter & Gamble

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.